RHO and ovarian carcinoma: Pharmacological inhibition of LPA-mediated stimulation of Rho/ROCK pathway decreases tumor aggressivenessInhibition of Rho/ROCK pathway blocks HIF-1α signaling and restores platinum sensitivity of ovarian cancer cells